Sitagliptin and its fixed dose combinations have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior
Share this article
If you liked this article share it with your friends.they will thank you later
/newsdrum-in/media/post_banners/eXYBsnsyOdudRiXrMUY5.jpg)
2 Min read
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg){kind=logo}
